Anjarium Biosciences
Pioneering the next generation of non-viral gene therapy
Schlieren, Switzerlandwww.anjarium.com ↗
Total raised
€51M
€50,961,567
Funding rounds
1
Investors
5
distinct backers
Active since
2021-09
latest 2021-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-16 | Series A | €51M | Abingworth,Gimv,Omega Funds,Pfizer Ventures,Surveyor Capital | View deal → |
Related news
- Anjarium Biosciences Raises CHF 55.5 Million Series A Financingstartupticker.ch · 2021-09
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy